1. Tumor microenvironment activated mussel-inspired hollow mesoporous nanotheranostic for enhanced synergistic photodynamic/chemodynamic therapy.
- Author
-
Tian Yan, Hao, Jang, Moon-Sun, Liu, Changling, Fu, Qiang, Wang, Bo, Fu, Yan, Hee Lee, Jung, and Yu Yang, Hong
- Subjects
- *
TUMOR microenvironment , *REACTIVE oxygen species , *MAGNETIC resonance imaging , *HYDROXYL group , *ETHYLENE glycol , *CONJUGATED polymers , *HYALURONIC acid - Abstract
[Display omitted] Anti-tumor therapies reliant on reactive oxygen species (ROS) as primary therapeutic agents face challenges due to a limited oxygen substrate. Photodynamic therapy (PDT) is particularly hindered by inherent hypoxia, while chemodynamic therapy (CDT) encounters obstacles from insufficient endogenous hydrogen peroxide (H 2 O 2) levels. In this study, we engineered biodegradable tumor microenvironment (TME)-activated hollow mesoporous MnO 2 -based nanotheranostic agents, designated as HAMnO 2 A. This construct entails loading artemisinin (ART) into the cavity and surface modification with a mussel-inspired polymer ligand, namely hyaluronic acid-linked poly(ethylene glycol)-diethylenetriamine-conjugated (3,4-dihydroxyphenyl) acetic acid, and the photosensitizer Chlorin e6 (mPEG-HA-Dien-(Dhpa/Ce6)), facilitating dual-modal imaging-guided PDT/CDT synergistic therapy. In vitro experimentation revealed that HAMnO 2 A exhibited ideal physiological stability and enhanced cellular uptake capability via CD44-mediated endocytosis. Additionally, it was demonstrated that accelerated endo -lysosomal escape through the pH-dependent protonation of Dien. Within the acidic and highly glutathione (GSH)-rich TME, the active component of HAMnO 2 A, MnO 2 , underwent decomposition, liberating oxygen and releasing both Mn2+ and ART. This process alleviates hypoxia within the tumor region and initiates a Fenton-like reaction through the combination of ART and Mn2+, thereby enhancing the effectiveness of PDT and CDT by generating increased singlet oxygen (1O 2) and hydroxyl radicals (•OH). Moreover, the presence of Mn2+ ions enabled the activation of T 1 -weighted magnetic resonance imaging. In vivo findings further validated that HAMnO 2 A displayed meaningful tumor-targeting capabilities, prolonged circulation time in the bloodstream, and outstanding efficacy in restraining tumor growth while inducing minimal damage to normal tissues. Hence, this nanoplatform serves as an efficient all-in-one solution by facilitating the integration of multiple functions, ultimately enhancing the effectiveness of tumor theranostics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF